Keefe Bruyette analyst Sanjay Sakhrani lowered the firm’s price target on Bill to $110 from $120 and keeps a Market Perform rating on the shares. The company’s Q2 results were solid, but macro headwinds are likely to remain a negative overhang for the name, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BILL: